المؤلفون: Y Nakayama (11424818), M Hashimoto (1401844), R Watanabe (11424821), K Murakami (6338000), K Murata (11424824), M Tanaka (46344), H Ito (1401829), W Yamamoto (5804033), K Ebina (11424827), K Hata (11424830), Y Hiramatsu (11424833), M Katayama (7391966), Y Son (6952046), H Amuro (6952040), K Akashi (11424836), A Onishi (11424839), R Hara (11424842), K Yamamoto (7725152), K Ohmura (5804036), S Matsuda (1401838), A Morinobu (11424845)

مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Pharmacology, Biotechnology, Ecology, Immunology, Developmental Biology, Cancer, Science Policy, Mental Health, Infectious Diseases, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, three groups according, phase reactant driven, observational multicentre registry, favourable therapeutic option, answer cohort study, 5 vs 48, 2 vs 67, specific clinical situation, favorable clinical response, high crp levels, baseline crp levels, treat rheumatoid arthritis, ra patients treated, ra patients according, 8 – 18, 6 receptor inhibitor

Relation: https://figshare.com/articles/journal_contribution/Favorable_clinical_response_and_drug_retention_of_anti-IL-6_receptor_inhibitor_in_rheumatoid_arthritis_with_high_CRP_levels_the_ANSWER_cohort_study/16610321

الاتاحة: https://doi.org/10.6084/m9.figshare.16610321.v1